An Open Label N of 1 Study to Evaluate the Safety and Efficacy of Long-Term Treatment with Ivacaftor in Combination with ALTALUREN (PTCD124) In Subjects with Nonsense Mutation Cystic Fibrosis

Grant

Date/time Interval

  • January 1, 2016 - December 31, 2017
  • Total Award Amount

  • 51500.00
  • Direct Costs

  • 46818.00
  • Sponsor Award Id

  • MDBR-16-120-CF1282x
  • Contributor

  • Hathorne, Heather   Investigator  
  • Rowe, Steven   Principal Investigator  
  • Solomon, George   Investigator